Indian Pharma Formulators To Benefit From New U.S. FDA Generic: Report
An employee collects Pentalgin tablets from a storage bin at a drug manufacturing unit in Kursk, Russia. (Photographer: Andrey Rudakov/Bloomberg)

Indian Pharma Formulators To Benefit From New U.S. FDA Generic: Report

Bookmark
The recent guidance from the US Food & Drug Administration on complex generics is expected to provide more clarity to the U.S.-focused Indian pharmaceutical formulators in preparing and submitting ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.